DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,570,173 | +3.0% | 179,646 | -0.3% | 2.62% | +7.4% |
| Q2 2023 | $43,252,320 | -6.7% | 180,218 | -2.0% | 2.44% | -13.3% |
| Q1 2023 | $46,354,036 | +93682.8% | 183,915 | -1.2% | 2.81% | -10.7% |
| Q4 2022 | $49,427 | -99.9% | 186,220 | -2.0% | 3.15% | -5.2% |
| Q3 2022 | $49,063,000 | +1.0% | 189,951 | -0.8% | 3.32% | +7.2% |
| Q2 2022 | $48,556,000 | -14.8% | 191,527 | -1.4% | 3.10% | +3.3% |
| Q1 2022 | $57,003,000 | -12.5% | 194,329 | -1.9% | 3.00% | -5.6% |
| Q4 2021 | $65,157,000 | +5.5% | 198,039 | -2.4% | 3.18% | -3.7% |
| Q3 2021 | $61,747,000 | +9.7% | 202,822 | -3.3% | 3.30% | +8.8% |
| Q2 2021 | $56,294,000 | +15.2% | 209,770 | -3.4% | 3.03% | +5.0% |
| Q1 2021 | $48,856,000 | -0.5% | 217,062 | -1.8% | 2.89% | -3.4% |
| Q4 2020 | $49,115,000 | +0.2% | 221,098 | -2.9% | 2.99% | -8.3% |
| Q3 2020 | $49,038,000 | +22.3% | 227,733 | +0.5% | 3.26% | +8.7% |
| Q2 2020 | $40,087,000 | +28.0% | 226,700 | +0.2% | 3.00% | +4.2% |
| Q1 2020 | $31,316,000 | -11.3% | 226,255 | -1.7% | 2.88% | +10.5% |
| Q4 2019 | $35,316,000 | +6.4% | 230,099 | +0.1% | 2.60% | -1.9% |
| Q3 2019 | $33,190,000 | +0.7% | 229,799 | -0.4% | 2.65% | +1.3% |
| Q2 2019 | $32,965,000 | +7.5% | 230,651 | -0.7% | 2.62% | +1.6% |
| Q1 2019 | $30,674,000 | +28.2% | 232,341 | +0.1% | 2.58% | +11.8% |
| Q4 2018 | $23,936,000 | -5.9% | 232,114 | -0.8% | 2.30% | +13.4% |
| Q3 2018 | $25,428,000 | +9.5% | 234,012 | -0.5% | 2.03% | +3.4% |
| Q2 2018 | $23,216,000 | +4.8% | 235,269 | +4.0% | 1.96% | +0.3% |
| Q1 2018 | $22,155,000 | +6.4% | 226,283 | +0.8% | 1.96% | +12.0% |
| Q4 2017 | $20,827,000 | +12.8% | 224,383 | +4.2% | 1.75% | +7.0% |
| Q3 2017 | $18,467,000 | +3.3% | 215,282 | +1.7% | 1.64% | +0.6% |
| Q2 2017 | $17,870,000 | +2.4% | 211,759 | +3.8% | 1.63% | -0.6% |
| Q1 2017 | $17,451,000 | +13.1% | 204,035 | +3.0% | 1.64% | +10.5% |
| Q4 2016 | $15,423,000 | +9.0% | 198,131 | +9.8% | 1.48% | +4.7% |
| Q3 2016 | $14,147,000 | -13.7% | 180,470 | +11.2% | 1.41% | -14.3% |
| Q2 2016 | $16,397,000 | +11.2% | 162,351 | +4.5% | 1.65% | +8.8% |
| Q1 2016 | $14,744,000 | +17.1% | 155,427 | +14.7% | 1.52% | +15.8% |
| Q4 2015 | $12,590,000 | +23.8% | 135,552 | +13.5% | 1.31% | +19.1% |
| Q3 2015 | $10,173,000 | +4.1% | 119,387 | +4.5% | 1.10% | +11.1% |
| Q2 2015 | $9,777,000 | +0.8% | 114,230 | +0.0% | 0.99% | +3.8% |
| Q1 2015 | $9,698,000 | -5.3% | 114,223 | -4.4% | 0.95% | -4.8% |
| Q4 2014 | $10,243,000 | +11.3% | 119,509 | -1.4% | 1.00% | +8.1% |
| Q3 2014 | $9,205,000 | -4.6% | 121,145 | -1.2% | 0.92% | -4.5% |
| Q2 2014 | $9,650,000 | +5.3% | 122,575 | +0.3% | 0.97% | -0.7% |
| Q1 2014 | $9,165,000 | -3.4% | 122,204 | -0.6% | 0.98% | -8.1% |
| Q4 2013 | $9,490,000 | +12.2% | 122,931 | +0.8% | 1.06% | +3.5% |
| Q3 2013 | $8,458,000 | +10.7% | 122,015 | +1.1% | 1.03% | +4.7% |
| Q2 2013 | $7,640,000 | – | 120,689 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |